# Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions

> **NCT06213610** · PHASE1 · UNKNOWN · sponsor: **Pharmtechnology LLC** · enrollment: 50 (estimated)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Perindopril tablet
- **DRUG:** Prestarium® A tablet

## Key facts

- **NCT ID:** NCT06213610
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-09
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213610, "Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06213610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*